301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

Bibliographic Details
Main Authors:	Ralf Gutzmer, Caroline Robert, Thomas Eigentler, Qian Zhu, Helen Gogas, Grant McArthur, Paolo Ascierto, Daniil Stroyakovskiy, Svetlana Protsenko, Rodrigo Pereira, Lev Demidov, Georgy Moiseevich Manikhas, Haocheng Li, Edward McKenna, Virginia McNally
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study
by: Ralf Gutzmer, et al.
Published: (2020-11-01)

Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report
by: Marco AJ Iafolla, et al.
Published: (2019-05-01)

Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials
by: Paolo A. Ascierto, et al.
Published: (2020-08-01)

Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib
by: Gavric Ana Ursula, et al.
Published: (2018-01-01)

The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib
by: Medina TM, et al.
Published: (2016-06-01)

Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients
by: Adil Daud, et al.
Published: (2017-01-01)

Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trials
by: Ashley M. Hopkins, et al.
Published: (2020-02-01)

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study
by: Katharina C. Kähler, et al.
Published: (2021-05-01)

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation
by: Ester Simeone, et al.
Published: (2021-01-01)

Role of vemurafenib in the treatment of disseminated skin melanoma
by: L V Demidov, et al.
Published: (2013-06-01)

Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study
by: Luis de la Cruz-Merino, et al.
Published: (2017-06-01)

Choroidal involvement in Rosai-Dorfman disease successfully treated with cobimetinib
by: Chiara Giuffrè, et al.
Published: (2020-01-01)

Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study
by: Bernies van der Hiel, et al.
Published: (2017-09-01)

VEMURAFENIB IN TREATMENT OF MELANOMA WITH BRAIN METASTASES
by: D. R. Naskhletashvili, et al.
Published: (2017-04-01)

Efficacy of the MEK Inhibitor Cobimetinib and its Potential Application to Colorectal Cancer Cells
by: Shu Gong, et al.
Published: (2018-05-01)

Cobimetinib‐induced “dropped head syndrome” and subsequent disease management in an Erdheim‐Chester patient
by: Amber C. King, et al.
Published: (2019-10-01)

Chomsky and Wittgenstein on Linguistic Competence
by: Thomas McNally, et al.
Published: (2012-11-01)

The distribution of Cat-301 immunoreactivity in the cerebral cortex
by: McGuire, Philip K.
Published: (1992)

The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes
by: Daniela Lulli, et al.
Published: (2017-10-01)

Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib
by: Letizia Porcelli, et al.
Published: (2021-01-01)

Metastatic melanoma and vemurafenib: novel approaches
by: Ramon Andrade De Mello
Published: (2012-04-01)

Delayed-onset vemurafenib-induced panniculitis
by: Stephen L. Vance, MD, MBA, et al.
Published: (2017-09-01)

Vemurafenib-induced bilateral facial palsy
by: FNU Shailesh, et al.
Published: (2014-01-01)

A Rare Cause of Uveitis: Vemurafenib
by: Selçuk Sızmaz, et al.
Published: (2018-12-01)

The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma
by: Hongmei Cui, et al.
Published: (2021-03-01)

A novel side effect of mitogen-activated protein kinase inhibitor cobimetinib: Acute corneal decompensation
by: Mahmut Asfuroglu, et al.
Published: (2019-01-01)

A Case of Perforating Folliculitis Induced by Vemurafenib
by: Ken Shiraishi, et al.
Published: (2018-10-01)

RASopathic skin eruptions during vemurafenib therapy.
by: Jeannine D Rinderknecht, et al.
Published: (2013-01-01)

ISTA 301
Published: (2014)

Sovremennyy podkhod k lecheniyu nerezektabel'noy i metastaticheskoy melanomy. Rol' ingibitorov BRAF i MEK
by: Daniil L'vovich Stroyakovskiy
Published: (2015-09-01)

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC
by: Ryo Toyozawa, MD, et al.
Published: (2020-03-01)

A textual analysis of Malcolm Baldrige National Quality Award recipients to explore best organizational communication models in American companies
by: McNally, Sean
Published: (2006)

Els plurals sense determinant en espanyol s’interpreten com a propietats
by: Louise McNally
Published: (2004-12-01)

Innovative teaching and technology in the service of science: Recruiting the next generation of STEM students
by: Thomas McNally
Published: (2012-05-01)

Innovative teaching and technology in the service of science: Recruiting the next generation of STEM students
by: Thomas McNally
Published: (2012-02-01)

Aspects of structural change on European farms : an empirical study
by: McNally, Sandra
Published: (2003)

The root nodule of alnus glutinosa l. gaertn. : a study in fine structure
by: McNally, S. F.
Published: (1980)

MOVING TOWARDS BEST PRACTICE FOR BIRD MORTALITY MITIGATION IN WIND POWER PLANNING, SWEDEN
by: McNally, Ross
Published: (2015)

Reading theories and telling stories in contemporary fiction
by: McNally, Lisa
Published: (2011)

Transition metal complexes of pyridyl functionalized n-heterocyclic carbenes
by: McNally, C. T.
Published: (2012)